INTEGRATE-HTA Ansgar Gerhardus for the INTEGRATE-HTA project team - - PowerPoint PPT Presentation

integrate hta
SMART_READER_LITE
LIVE PREVIEW

INTEGRATE-HTA Ansgar Gerhardus for the INTEGRATE-HTA project team - - PowerPoint PPT Presentation

Department of Health Service Research Head: Prof. Dr. Ansgar Gerhardus Integrated health technology assessment for the evaluation of complex technologies INTEGRATE-HTA Ansgar Gerhardus for the INTEGRATE-HTA project team INTEGRATE-HTA Aim of


slide-1
SLIDE 1

Department of Health Service Research Head: Prof. Dr. Ansgar Gerhardus

Integrated health technology assessment for the evaluation of complex technologies

INTEGRATE-HTA

Ansgar Gerhardus for the INTEGRATE-HTA project team

INTEGRATE-HTA

slide-2
SLIDE 2

Aim of INTEGRATE-HTA

To develop concepts and methods for a comprehensive,

patient–centred, and integrated (as opposed to side-by-side) assessment of complex technologies

that includes and considers

  • effectiveness and economic, sociocultural, ethical, and legal issues,
  • patient preferences and patient-specific moderators of treatment,
  • context and implementation issues.

INTEGRATE-HTA

2

slide-3
SLIDE 3

Starting point: HTA-Definition

HTA is a “…multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner…”

(EUnetHTA n.d.)

INTEGRATE-HTA

3

slide-4
SLIDE 4

INTEGRATE-HTA

1) Modulating factors

Patient characteristics Implementation Context Findings/ Outcomes

  • Early or late

stage

  • Personal

preferences

  • Professionals
  • Relatives
  • Non-related

lay persons

  • Elaborated

palliative care system at place? Medical Social/Cultural Economic Ethical Legal 5

slide-5
SLIDE 5

INTEGRATE-HTA

1) Impact of modulating factors on outcomes

Patient characteristics Implementation Context Findings/ Outcomes

  • Early or late

stage

  • Personal

preferences

  • Professionals
  • Relatives
  • Non-related

lay persons

  • Elaborated

palliative care system at place? Medical Social/Cultural Economic Ethical Legal 6

slide-6
SLIDE 6

INTEGRATE-HTA

  • For the assessment of complex technologies

implementation, context, patient characteristics and interactions matter

Observation 1

7

slide-7
SLIDE 7

HTA is a “…multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner…”

(EUnetHTA n.d.)

INTEGRATE-HTA

HTA-Definition

8

slide-8
SLIDE 8

INTEGRATE-HTA

Patient characteristics Implementation Context Findings/ Outcomes

  • Early or late

stage

  • Personal

preferences

  • Professionals
  • Relatives
  • Non-related

lay persons

  • Elaborated

palliative care system at place? Medical Social/Cultural

+

Economic

+

Ethical

+

Legal

+

2) Aggregating outcomes

9

slide-9
SLIDE 9

INTEGRATE-HTA

Patient characteristics Implementation Context Findings/ Outcomes

  • Early or late

stage

  • Personal

preferences

  • Professionals
  • Relatives
  • Non-related

lay persons

  • Elaborated

palliative care system at place? Medical Social/Cultural Economic Ethical Legal

2) Aggregating outcomes

Integration

10

slide-10
SLIDE 10

INTEGRATE-HTA

  • For complex technologies decision-makers need assessment-

information in an integrated (not aggregated) way and integration needs to start from the beginning of the assessment

Observation 2

11

slide-11
SLIDE 11

Structure of INTEGRATE-HTA

INTEGRATE-HTA

WP6: Integration

WP7: Case study palliative care

WP8: Testing on other technologies

WP 3: Assessment issues of complex technologies

WP 5: Context & implementation WP4: Patients‘ preferences and moderators

12

slide-12
SLIDE 12

The outcome – structured by the INTEGRATE-HTA Process Model

INTEGRATE-HTA

13

slide-13
SLIDE 13

Step 1: Bringing evidence generation into perspective

INTEGRATE-HTA

  • Input through Stakeholder Advisory

Panels (SAPs): Topics, objectives, patient groups, context and implementation

14

slide-14
SLIDE 14

INTEGRATE-HTA

Step 2: Patient characteristics and Logic Model

  • Creating a logic model taking patient

characteristics, implementation issues and context into account

  • Structuring patient heterogeneity into

groups of patients with certain characteristics

15

slide-15
SLIDE 15

INTEGRATE-HTA

Step 3: Assessing the Evidence

  • Systematic reviews and other methods

with focus on the objective of the HTA

16

slide-16
SLIDE 16

INTEGRATE-HTA

Step 4: Inserting the evidence into the logic model

  • Evidence is inserted into the logic model
  • HTA-process might end here and feed

directly into Step 6: Structured deliberative decision-making

17

slide-17
SLIDE 17

INTEGRATE-HTA

Step 5: Reducing complexity (optional)

  • Employing decision support tools (e.g.

Multi Criteria Decision Making / MCDA- type) to reduce complexity

18

slide-18
SLIDE 18

INTEGRATE-HTA

Step 6: Structured deliberative decision-making

  • Structured process of decision-makers

taking uncertainty, unanswered questions, and limitations into account

19

slide-19
SLIDE 19

Products: Guidances and “Demonstration-HTA”

1. Guidance for the assessment of effectiveness, and economic, ethical, socio- cultural, and legal issues of complex technologies 2. Guidance for retrieving and critical appraisal of the literature on moderators of treatment effects and for the critical appraisal of articles concerning patient preferences for treatment outcomes 3. Guidance for the assessment of context and implementation in systematic reviews and health technology assessments of complex interventions and for the use of logic models in systematic reviews and health technology assessments of complex interventions 4. Guidance for an integrated assessment of complex health technologies 5. Demonstration HTA on reinforced models on home based palliative care

INTEGRATE-HTA

20

slide-20
SLIDE 20

Lessons learnt

  • (Relationships between) intervention, patient characteristics,

implementation, and context need to be identified and modelled for the assessment of any complex technology

  • A defined perspective is necessary for an integrated assessment
  • Integration is a process that needs to start from the beginning

INTEGRATE-HTA

21

slide-21
SLIDE 21

Potential future collaborations

EU-projects: Applying the guidances on hospital-based HTA, medical devices, rare diseases EUNetHTA: Expanding the core model for the assessment of complex technologies HTA-agencies: Exchange on using and refining the guidances

INTEGRATE-HTA

22

slide-22
SLIDE 22

Rob Baltussen Andrew Booth Louise Brereton Jan Brönneke Benedikt Buchner Jake Burns Kate E.Chadwick Jim B.Chilcott Clare Gardiner Silvina Gazzoli Ansgar Gerhardus Tamara Gerissen Elizabeth C. (Liddy) Goyder Bjørn Hofmann Ralph von Hoorn Christine MC Ingleton Wietske Kievit Kristin Bakke Lysdahl Ulrich Mansmann Kati Mozygemba Martina De Nicola Bill Noble Per Nortvedt Wija Oortwijn Lisa Pfadenhauer Stephanie Polus Pietro Refolo Eva Rehfuess Anke Rohwer Dario Sacchini Imke Schilling Antonio G. Spagnolo Peep Stalmeier Marcia Tummers Adriana Turriziani Gert Jan van der Wilt Philip Wahlster Vivienne (Viv)Walker Sue Ward Kim Weistra

17

This project is co-funded by the European Union under the Seventh Framework Programme (Grant Agreement No. 306141)

slide-23
SLIDE 23

Please join us at the final conference of the INTEGRATE-HTA-Project at 12./13. November in Amsterdam

→ www.integrate-hta.eu

http://www.iamsterdam.com

INTEGRATE-HTA